简 EN 繁
简 EN 繁

Please enter the information you want to find

Hot key words：
Hyaluronidase xxx
News Center News Center

News Center

2025.12.10

​Shanghai Bao Pharma Successfully Listed on the Hong Kong Stock Exchange, Ushering in a New Era of Recombinant Biologics

View details
​Shanghai Bao Pharma Successfully Listed on the Hong Kong Stock Exchange, Ushering in a New Era of Recombinant Biologics
Initiation of KJ103 Phase III Clinical Trial China's Innovative Drug Opens a New Era for Anti-GBM Disease Treatment
2025.12.28

Initiation of KJ103 Phase III Clinical Trial China's Innovative Drug Opens a New Era for Anti-GBM Disease Treatment

View details
Pharma News | How Bao Pharma Demonstrates Differentiated Breakthrough
2025.12.26

Pharma News | How Bao Pharma Demonstrates Differentiated Breakthrough

View details
Exploring the Frontiers of Clinical Innovation: Bao Pharma Participating in the National Xenotransplantation Mega-Project
2025.12.12

Exploring the Frontiers of Clinical Innovation: Bao Pharma Participating in the National Xenotransplantation Mega-Project

View details
【News】Bao Pharma's Recombinant Human Hyaluronidase Successfully Registered in the U.S. FDA DMF
2025.05.16

【News】Bao Pharma's Recombinant Human Hyaluronidase Successfully Registered in the U.S. FDA DMF

View details
123